Cargando…

Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer

BACKGROUND: There is an intimate crosstalk between cancer formation, dissemination, treatment response and the host immune system, with inducing tumour cell death the ultimate therapeutic goal for most anti-cancer treatments. However, inducing a purposeful synergistic response between conventional t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donlon, Noel E, Davern, Maria, Sheppard, Andrew, O'Connell, Fiona, Moran, Brendan, Nugent, Timothy S, Heeran, Aisling, Phelan, James J, Bhardwaj, Anshul, Butler, Christine, Ravi, Narayanasamy, Donohoe, Claire L, Lynam-Lennon, Niamh, Maher, Stephen, Reynolds, John V, Lysaght, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473939/ https://www.ncbi.nlm.nih.gov/pubmed/37663943 http://dx.doi.org/10.4251/wjgo.v15.i8.1349

Ejemplares similares

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
por: Davern, Maria, et al.
Publicado: (2021)

PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours
por: Davern, Maria, et al.
Publicado: (2022)

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
por: Davern, Maria, et al.
Publicado: (2023)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
por: Davern, Maria, et al.
Publicado: (2022)

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
por: Heeran, Aisling B., et al.
Publicado: (2021)

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
por: Donlon, Noel E., et al.
Publicado: (2020)

Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
por: Mylod, Eimear, et al.
Publicado: (2022)

PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

Altered Mitochondrial Function and Energy Metabolism Is Associated with a Radioresistant Phenotype in Oesophageal Adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma
por: O’Connell, Fiona, et al.
Publicado: (2023)

The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
por: Donlon, Noel E., et al.
Publicado: (2022)

Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma
por: Mongan, Ann Marie, et al.
Publicado: (2019)

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma
por: Buckley, Amy M., et al.
Publicado: (2018)

Synergise or perish
por: Grover, Harpreet Singh
Publicado: (2021)

Complement in Tumourigenesis and the Response to Cancer Therapy
por: O’Brien, Rebecca M., et al.
Publicado: (2021)

The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses
por: Heeran, Aisling B., et al.
Publicado: (2021)

Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play
por: Donlon, Noel E., et al.
Publicado: (2021)

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib
por: Buckley, Amy M., et al.
Publicado: (2020)

Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model
por: Heeran, Aisling B., et al.
Publicado: (2020)

Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers
por: Alhusaini, Abdullah, et al.
Publicado: (2021)

MYCN and mutationally activated ALK synergise in neuroblastoma
Publicado: (2012)

The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism
por: Mylod, Eimear, et al.
Publicado: (2021)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)

Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemic
por: Bolger, Jarlath C., et al.
Publicado: (2021)

Advances in the curative management of oesophageal cancer
por: Bolger, Jarlath C., et al.
Publicado: (2021)

Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
por: King, Ross, et al.
Publicado: (2021)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
por: Buckley, Amy M., et al.
Publicado: (2019)

Management of chyle leaks following esophageal resection: a systematic review
por: Power, Robert, et al.
Publicado: (2021)

Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype
por: Lynam-Lennon, Niamh, et al.
Publicado: (2016)

Thinking inside the box: intracellular roles for complement system proteins come into focus
por: O’Brien, Rebecca M., et al.
Publicado: (2023)

A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
por: Dean, E J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rsc6pf57v3evdl2tcanr75mnkc